Your browser doesn't support javascript.
loading
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
Shimada, Satoko; Yoshida, Reiko; Nakashima, Eri; Kitagawa, Dai; Gomi, Naoya; Horii, Rie; Takeuchi, Sayoko; Ashihara, Yuumi; Kita, Mizuho; Akiyama, Futoshi; Ohno, Shinji; Saito, Mitsue; Arai, Masami.
Afiliação
  • Shimada S; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.
  • Yoshida R; Department of Breast Oncology, Juntendo University, Tokyo, Japan.
  • Nakashima E; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan. reiko.yoshida@jfcr.or.jp.
  • Kitagawa D; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Gomi N; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Horii R; Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takeuchi S; Diagnostic Imaging Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ashihara Y; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kita M; Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Akiyama F; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.
  • Ohno S; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.
  • Saito M; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.
  • Arai M; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Breast Cancer ; 26(6): 846-851, 2019 Nov.
Article em En | MEDLINE | ID: mdl-30980249
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Programas de Rastreamento / Proteína BRCA1 / Genes BRCA1 / Proteína BRCA2 / Genes BRCA2 / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Programas de Rastreamento / Proteína BRCA1 / Genes BRCA1 / Proteína BRCA2 / Genes BRCA2 / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Japão